Sign up to save your podcasts
Or
Share Modernizing cell therapy manufacturing to reduce vein-to-vein times
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Modernizing cell therapy manufacturing to reduce vein-to-vein times
Charlotte Barker (Editor, BioInsights) speaks with Curate Biosciences’ CEO David Backer and CTO Tony Ward about the need for CAR-T cell therapy manufacturing to evolve, and how a new cell separation technique could boost efficiency.
View all episodes
By BioInsightsCharlotte Barker (Editor, BioInsights) speaks with Curate Biosciences’ CEO David Backer and CTO Tony Ward about the need for CAR-T cell therapy manufacturing to evolve, and how a new cell separation technique could boost efficiency.